Instead of managing symptoms, there is now an option to treat the underlying cause for the individuals who qualify
Nearly 89% of participants receiving the highest dose achieved at least 5% weight loss, compared to just 15.6% of those taking a placebo
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend considering GLP-1R agonists for T2DM patients who do not have established CVD but are at high risk for ASCVD
In recent years, diabetes patients have gained more therapeutic options thanks to the rise of next-generation GLP-1 analogs
For one, it can hurt your self-confidence at work or in social settings, and depending on the type of acne and severity, it can be pretty painful (cystic acne tends to be considerably more painful)
If you are still deciding whether prescription support is right for you, you can also complete a free eligibility assessment